Lifecore Biomedical Income Statement

Financials in millions USD. Fiscal year is June - May.

Millions USD. Fiscal year is Jun - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '25 May 25, 2025	May '24 May 26, 2024	May '23 May 28, 2023	May '22 May 29, 2022	May '21 May 30, 2021
Revenue	128.87	128.26	103.27	111.27	100.87
Revenue Growth (YoY)	0.47%	24.20%	-7.19%	10.31%	-36.98%
Cost of Revenue	88.57	86.41	75.28	72.2	61.94
Gross Profit	40.3	41.85	27.99	39.07	38.94
Selling, General & Admin	44.05	40.46	38.97	34.66	29.32
Research & Development	8.26	8.58	8.74	7.84	6.68
Operating Expenses	52.3	49.04	47.71	42.5	36.01
Operating Income	-12.01	-7.19	-19.72	-3.43	2.93
Interest Expense	-21.84	-18.09	-17.58	-15.47	-8.93
Interest & Investment Income	-	-	-	-	0.05
Other Non Operating Income (Expenses)	0.41	36.45	-0.81	6.57	-10.97
EBT Excluding Unusual Items	-33.44	11.17	-38.11	-12.33	-16.92
Merger & Restructuring Charges	1.75	-1.66	-4.18	-8.36	-13.36
Gain (Loss) on Sale of Assets	-6.99	-	2.11	-	-
Other Unusual Items	-	-	-23.74	-	-1.11
Pretax Income	-38.67	9.51	-63.93	-20.69	-29.79
Income Tax Expense	0.04	0.18	0.31	-5.21	-6.35
Earnings From Continuing Operations	-38.72	9.33	-64.24	-15.48	-23.44
Earnings From Discontinued Operations	-	2.68	-35.33	-101.24	-8.86
Net Income to Company	-38.72	12.01	-99.56	-116.72	-32.29
Net Income	-38.72	12.01	-99.56	-116.72	-32.29
Preferred Dividends & Other Adjustments	5.64	-	-	-	-
Net Income to Common	-44.36	12.01	-99.56	-116.72	-32.29
Shares Outstanding (Basic)	35	30	30	29	29
Shares Outstanding (Diluted)	35	37	30	29	29
Shares Change (YoY)	-5.02%	22.36%	1.67%	0.59%	0.45%
EPS (Basic)	-1.27	0.39	-3.32	-3.96	-1.10
EPS (Diluted)	-1.27	0.33	-3.32	-3.97	-1.10
Free Cash Flow	-13.62	-18.14	-38.92	-52.53	-8.75
Free Cash Flow Per Share	-0.39	-0.49	-1.30	-1.78	-0.30
Gross Margin	31.27%	32.63%	27.10%	35.11%	38.60%
Operating Margin	-9.32%	-5.60%	-19.10%	-3.08%	2.91%
Profit Margin	-34.42%	9.37%	-96.41%	-104.89%	-32.01%
Free Cash Flow Margin	-10.57%	-14.14%	-37.69%	-47.21%	-8.68%
EBITDA	-3.98	0.77	-7.04	14.23	8.13
EBITDA Margin	-3.09%	0.60%	-6.82%	12.79%	8.06%
D&A For EBITDA	8.03	7.95	12.68	17.66	5.2
EBIT	-12.01	-7.19	-19.72	-3.43	2.93
EBIT Margin	-9.32%	-5.60%	-19.10%	-3.08%	2.91%
Effective Tax Rate	-	1.92%	-	-	-
Revenue as Reported	128.87	128.26	103.27	111.27	-
Advertising Expenses	-	-	0.01	0.01	0

Source: S&P Global Market Intelligence. Standard template. Financial Sources.